| |
| |
|
| Insider
Information: |
Frazier Alan D |
| Relationship: |
Director, 10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
38,802 |
|
|
Indirect Shares
|
2,183,127 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,221,929 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
Director |
2004-02-19 |
0 |
2005-11-28 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2010-01-26 |
38,802 |
2010-01-26 |
2,183,127 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
Director, 10% Owner |
2006-10-30 |
0 |
2014-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • • |
2014-03-19 |
4 |
D |
$14.00 |
$120,584,590 |
I/I |
(8,613,185) |
0 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • • |
2014-02-12 |
4 |
D |
$14.00 |
$13,625,318 |
I/I |
(973,237) |
4,796,711 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • • |
2014-02-12 |
4 |
OE |
$7.84 |
$13,625,301 |
I/I |
1,737,921 |
4,894,035 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2010-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
21,008 |
38,802 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • • |
2009-02-18 |
4 |
A |
$7.13 |
$24,782,753 |
I/I |
3,475,842 |
4,720,243 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2009-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
17,794 |
17,794 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • • |
2008-02-20 |
4 |
A |
$5.34 |
$9,999,999 |
I/I |
1,872,659 |
4,372,659 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-10-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500,000 |
2,500,000 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2006-03-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,183,127 |
1,586,752 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2005-11-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
10,905 |
0 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2005-01-25 |
4 |
S |
$19.10 |
$44,541 |
I/I |
(2,332) |
0 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2005-01-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(940,959) |
0 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2005-01-24 |
4 |
A |
$0.00 |
$0 |
I/I |
4,917 |
10,905 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2004-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,012 |
5,988 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2004-05-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(459,564) |
943,292 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2004-05-20 |
4 |
S |
$17.61 |
$41,082 |
I/I |
(2,333) |
0 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2004-04-05 |
4 |
S |
$22.76 |
$57,457 |
I/I |
(2,524) |
0 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2004-04-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(497,475) |
1,405,989 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2004-04-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,294 |
3,976 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-02-24 |
4/A |
D |
$23.55 |
$1,499,876 |
I/I |
(63,689) |
1,906,872 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-02-24 |
4/A |
OE |
$5.76 |
$1,499,996 |
I/I |
260,416 |
1,970,561 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-02-24 |
4 |
D |
$23.55 |
$1,499,876 |
I/I |
(63,689) |
1,903,453 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-02-24 |
4 |
OE |
$5.76 |
$1,499,996 |
I/I |
260,416 |
1,967,141 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-02-19 |
4/A |
S |
$18.80 |
$1,410,320 |
I/I |
(75,017) |
1,710,145 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • • |
2004-02-19 |
4 |
S |
$18.80 |
$1,474,597 |
I/I |
(78,436) |
1,706,726 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
